RAM SINGH: Open Payments
NPI 1891774568 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 33 payments from 12 companies in 2025. Trend: 2023 $313 · 2024 $781 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $135 |
| Merck Sharp & Dohme LLC | 4 | $131 |
| Amgen Inc. | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Boston Scientific Corporation | 2 | $54 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $54 |
| BridgeBio Pharma, Inc. | 1 | $36 |
| CVRx, Inc. | 1 | $34 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
Products named: VERQUVO, REPATHA, VYNDAQEL, LEQVIO, CAMZYOS, WATCHMAN FLX, LifeVest, ELIQUIS.
Industry payments across NV — which companies pay providers there.
